Jump to content

B-Man

Community Member
  • Posts

    67,755
  • Joined

  • Last visited

Posts posted by B-Man

  1.  

    Gary Varvel Comic Strip for March 24, 2020
     
     
     
     
     
    .
     
     
     
    Just now, Taro T said:

    Does anybody know where in the Senate bill the "$500,000,000,000 slush fund" talking point comes from?  It looks like the "discretionary" money available for distribution to large businesses is $150B.  Didn't see a cap on the size of the loan/ loan forgiveness program for small businesses, but did see a cap on individual loans at $10MM.  Maybe that program is estimated to be $350B, but that doesn't seem likely.

     

     

    one of the sticking points in the negotiations is the $500 billion “Exchange Stabilization Fund,” which the Democrats refer to as “a slush fund.” They are concerned that Mnuchin would have too much discretion “over which industries would have access to the fund.”

     

     

    On Monday evening, Mnuchin appeared on Fox Business and said, “It’s not a slush fund; it’s a mechanism that we can use working with the Federal Reserve that will provide another $4 trillion of potential liquidity into the market. That’s on top of the Fed’s balance sheet.”

     

    Late Monday night, Politico reporter John Bresnahan tweeted, “Mnuchin has agreed to “significant oversight” over $500B “Exchange Stabilization Fund,” per 3 sources. This is a major issue for Democrats, who called it a “$500 billion slush fund” with no accountability.”

     

     

    .

    • Like (+1) 1
    • Thank you (+1) 1
  2.  

     

    KRUISER’S MORNING BRIEF: A Hit List of Righteous Republican Anger From the Senate Floor. “After being the worst people on Earth on Sunday, Senate Democrats doubled-down on Monday and decided to be the worst people in history and continue blocking the coronavirus relief package all because Granny Boxwine showed up with a fetish list of progressive nonsense that made Chuck Schumer dance like a little puppet.”

     

     

     

     

     

     

    THIS DOES SEEM TO BE THE PLAN:

    Screen-Shot-2020-03-24-at-9.40.59-AM.png

     

     

     

     

     

    Pelosi’s Coronavirus Stimulus Bill Mentions ‘Diversity’ 32 Times

    by Andrew Stiles

    Original Article

     

     

     

    .

  3. TREATMENTS: These Drugs Are Helping Our Coronavirus Patients:

     

    A flash of potential good news from the front lines of the coronavirus pandemic: A treatment is showing promise. Doctors in France, South Korea and the U.S. are using an antimalarial drug known as hydroxychloroquine with success. We are physicians treating patients with Covid-19, and the therapy appears to be making a difference. It isn’t a silver bullet, but if deployed quickly and strategically the drug could potentially help bend the pandemic’s “hockey stick” curve.

     

    Hydroxychloroquine is a common generic drug used to treat lupus, arthritis and malaria. The medication, whose brand name is Plaquenil, is relatively safe, with the main side effect being stomach irritation, though it can cause echocardiogram and vision changes. In 2005, a Centers for Disease Control and Prevention study showed that chloroquine, an analogue, could block a virus from penetrating a cell if administered before exposure. If tissue had already been infected, the drug inhibited the virus.

     

    On March 9 a team of researchers in China published results showing hydroxychloroquine was effective against the 2019 coronavirus in a test tube. The authors suggested a five-day, 12-pill treatment for Covid-19: two 200-milligram tablets twice a day on the first day followed by one tablet twice a day for four more days.

     

    A more recent French study used the drug in combination with azithromycin. Most Americans know azithromycin as the brand name Zithromax Z-Pak, prescribed for upper respiratory infections. The Z-Pak alone doesn’t appear to help fight Covid-19, and the findings of combination treatment are preliminary.

     

    But researchers in France treated a small number of patients with both hydroxychloroquine and a Z-Pak, and 100% of them were cured by day six of treatment. Compare that with 57.1% of patients treated with hydroxychloroquine alone, and 12.5% of patients who received neither.

    What’s more, most patients cleared the virus in three to six days rather than the 20 days observed in China. That reduces the time a patient can spread the virus to others. One lesson that should inform the U.S. approach: Use this treatment cocktail early, and don’t wait until a patient is on a ventilator in the intensive-care unit.

     

    A couple of careful studies of hydroxychloroquine are in progress, but the results may take weeks or longer. Infectious-disease experts are already using hydroxychloroquine clinically with some success. With our colleague Dr. Joe Brewer in Kansas City, Mo., we are using hydroxychloroquine in two ways: to treat patients and as prophylaxis to protect health-care workers from infection. . . . As a matter of clinical practice, hydroxychloroquine should be given early to patients who test positive, and perhaps if Covid-19 is presumed—in the case of ill household contacts, for instance.

     

     

     

    Good. Sounds promising.

     

     

     

     

     

     

     

    Moving Past the Quarantine

    by Arpit Gupta

    Original Article

     

     

     

     

     

    .

    • Thank you (+1) 2
×
×
  • Create New...